FTC Issues Final Rule Regarding Unqualified “Made in the USA” Label Claims
On July 1, 2021, the Federal Trade Commission (“FTC” or “the Commission”) announced that it was finalizing the Made in USA Labeling … more
enforcement policy
Strong Medicine? After Decades of Diluted Enforcement, FDA Issues Draft Guidance Announcing New Enforcement Policy for Homeopathic Drugs That Takes a Risk-Based Approach
On December 18, 2017, the U.S. Food and Drug Administration (FDA) issued its long-awaited Draft Guidance for Industry: Drug Products Labeled as … more